{"paper_id":"91a77b1f-fa2a-473f-bbf1-7ded645e5a42","body_text":"Abstract\nFor symptomatic patients with adenomyosis, a variety of treatment options are available based on the patient’s age, physical and psychological needs, and traditional treatment methods. These treatments include surgical removal, subtotal hysterectomy, or total hysterectomy. However, the surgical removal of adenomyosis is difficult and not satisfactory for diffuse adenomyosis; thus, it is not often performed. Adenomyosis also increasingly begins at a younger age of onset, and there is a need to retain the uterus. In addition to the above surgical treatment, oral contraceptives, Mirena (LNG-IUS), gonadotropin-releasing hormone agonist (GnRH-a), and other conservative treatments are also options for managing adenomyosis. The poor compliance of long-term oral contraceptives, the irregular vaginal bleeding after LNG-IUS, and menopausal symptoms of the expensive GnRH-a contribute to the short-term use of these methods. Therefore, for patients who require treatment for their symptoms, but unwilling to undergo surgical treatment because they are afraid of surgery or have other reasons not to undergo surgery (such as medical and surgical contraindications or religious beliefs), there is a choice of uterine artery embolization (UAE) method. This interventional embolization technology has a history of nearly 20 years and has achieved satisfactory clinical efficacy [1]. Its advantages are the preservation of the uterus, easy operation, quick recovery after surgery, and few postoperative complications. Therefore it has become one of the effective alternatives in the treatment of symptomatic adenomyosis.\nAccess this chapter\nTax calculation will be finalised at checkout\nPurchases are for personal use only\nSimilar content being viewed by others\nReferences\nde Bruijn AM, et al. Uterine artery embolization for the treatment of adenomyosis: a systematic review and meta-analysis. J Vasc Interv Radiol. 2017;28(12):1629–1642. e1.\nKeung JJ, Spies JB, Caridi TM. Uterine artery embolization: a review of current concepts. Best Pract Res Clin Obstet Gynaecol. 2018;46:66–73.\nVon Korff M, et al. Grading the severity of chronic pain. Pain. 1992;50(2):133–49.\nDeshmukh SP, et al. Role of MR imaging of uterine leiomyomas before and after embolization. Radiographics. 2012;32(6):E251–81.\nChapron C, et al. Relationship between the magnetic resonance imaging appearance of adenomyosis and endometriosis phenotypes. Hum Reprod. 2017;32(7):1393–401.\nLiu Ruilei DE, Chunlin C, Ping L. The construction of digital three-dimensional model of the pelvic and abdominal pelvic artery vascular network and its application in the uterine arterial embolism entrance planning. Chinese Journal of Obstetrics and Gynecology. 2014;002:89–93.\nChen Chunlin CL, Lei T, Ping L, Jianxuan L, Bin C, Hui D, Jun W. The digital three-dimensional model of the abdominal pelvic vascular guides the selection of intravascular intervention intubation. Chinese Journal of cardiovascular diseases. 2015;24(3):252–6.\nJiang Bingyang LP. The choice of 3D reconstruction technology and individual treatment options for uterine adenomyosis. Chinese Journal of Practical Gynaecology and Obstetrics. 2017;33(2):141–5.\nWorthington-Kirsch R, et al. The Fibroid registry for outcomes data (FIBROID) for uterine embolization: short-term outcomes. Obstet Gynecol. 2005;106(1):52–9.\nAuthor information\nAuthors and Affiliations\nEditor information\nEditors and Affiliations\nRights and permissions\nCopyright information\n© 2021 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.\nAbout this chapter\nCite this chapter\nFan, Z. (2021). Uterine Artery Embolization Treatment for Adenomyosis. In: Xue, M., Leng, J., Wong, F. (eds) Adenomyosis. Springer, Singapore. https://doi.org/10.1007/978-981-33-4095-4_12\nDownload citation\nDOI: https://doi.org/10.1007/978-981-33-4095-4_12\nPublished:\nPublisher Name: Springer, Singapore\nPrint ISBN: 978-981-33-4094-7\nOnline ISBN: 978-981-33-4095-4\neBook Packages: MedicineMedicine (R0)","source_license":"CC0","license_restricted":false}